https://www.selleckchem.com/pr....oducts/crenolanib-cp
Relapse of leprosy among patients released from treatment (RFT) is an indicator of the success of anti-leprosy treatment. Due to inadequate follow-up, relapse in leprosy patients after RFT is not systematically documented in India. Relapsed leprosy patients pose a risk in the transmission of leprosy bacilli. We determined the incidence of relapse and deformity among the patients RFT from the leprosy control programme in four districts in South India. We conducted two follow-up surveys in 2012 and 2014 among the leprosy pati
Like
Comment
Share
